沈峰,范建高

• 1:上海交通大学医学院附属新华医院消化内科

摘要(Abstract)：

<正>非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)是欧美发达国家以及我国经济较发达地区第一大慢性肝病,是当代肝脏病学领域的新挑战。除了本领域杂志外,内分泌代谢、心血管、营养、儿科学等杂志也对其有越来越多的相关研究发表,表明NAFLD既是一种肝脏疾病又是全身系统性疾病在肝脏的累积,NAFLD作为代谢综合征(metabolic syndrome,MS)的重要组

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation): 国家重点基础研究发展计划项目(973计划,2012CB517501);; 上海交通大学医学院附属新华医院院长基金项目(12QYJ05)

作者(Author): 沈峰,范建高

参考文献(References)：

• [1]Zelber-Sagi S,Lotan R,Shlomai A,et al.Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up[J].J Hepatol,2012,56(5):1145-1151.
• [2]Armstrong MJ,Houlihan DD,Bentham L,et al.Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort[J].J Hepatol,2012,56(1):234-240.
• [3]Sinn DH,Gwak GY,Park HN,et al.Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese,non-diabetic middle-aged Asian adults[J].Am J Gastroenterol,2012,107(4):561-567.
• [4]Petta S,Grimaudo S,Camma C,et al.IL28B and PNPLA3polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease[J].J Hepatol,2012,56(6):1356-1362.
• [5]Vescovo T,Romagnoli A,Perdomo AB,et al.Autophagy protects cells from HCV-induced defects in lipid metabolism[J].Gastroenterology,2012,142(3):644-653.e3.
• [6]Guy CD,Suzuki A,Zdanowicz M,et al.Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease[J].Hepatology,2012,55(6):1711-1721.
• [7]Syn WK,Agboola KM,Swiderska M,et al.NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease[J].Gut,2012,61(9):1323-1329.
• [8]Kowdley KV,Belt P,Wilson LA,et al.Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease[J].Hepatology,2012,55(1):77-85.
• [9]Lomonaco R,Ortiz-Lopez C,Orsak B,et al.Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease[J].Hepatology,2012,55(5):1389-1397.
• [10]Gaens KH,Niessen PM,Rensen SS,et al.Endogenous formation of Nepsilon-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis[J].J Hepatol,2012,56(3):647-655.
• [11]Yu C,Xu C,Xu L,et al.Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease[J].J Hepatol,2012,56(1):241-247.
• [12]Shen J,Chan HL,Wong GL,et al.Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers[J].J Hepatol,2012,56(6):1363-1370.
• [13]Kornek M,Lynch M,Mehta SH,et al.Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis[J].Gastroenterology,2012,143(2):448-458.
• [14]Urdzik J,Bjerner T,Wanders A,et al.The value of pre-operative magnetic resonance spectroscopy in the assessment of steatohepatitis in patients with colorectal liver metastasis[J].J Hepatol,2012,56(3):640-646.
• [15]Myers RP,Pomier-Layrargues G,Kirsch R,et al.Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients[J].Hepatology,2012,55(1):199-208.
• [16]de Ledinghen V,Wong VW,Vergniol J,et al.Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement:comparison between M and XL probe of FibroScan(R)[J].J Hepatol,2012,56(4):833-839.
• [17]Myers RP,Pollett A,Kirsch R,et al.Controlled Attenuation Parameter(CAP):a noninvasive method for the detection of hepatic steatosis based on transient elastography[J].Liver Int,2012,32(6):902-910.
• [18]Reddy SK,Steel JL,Chen HW,et al.Outcomes of curative treatment for hepatocellular cancer in nonalcoholicsteatohepatitis versus hepatitis C and alcoholic liver disease[J].Hepatology,2012,55(6):1809-1819.
• [19]Kawamura Y,Arase Y,Ikeda K,et al.Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma[J].Am J Gastroenterol,2012,107(2):253-261.
• [20]Kim D,Choi SY,Park EH,et al.Nonalcoholic fatty liver disease is associated with coronary artery calcification[J].Hepatology,2012,56(2):605-613.
• [21]Musso G,Cassader M,De Michieli F,et al.Nonalcoholic steatohepatitis versus steatosis:adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism[J].Hepatology,2012,56(3):933-942.
• [22]Loomba R,Abraham M,Unalp A,et al.Association between diabetes,family history of diabetes,and risk of nonalcoholic steatohepatitis and fibrosis[J].Hepatology,2012,56(3):943-951.
• [23]Chung GE,Kim D,Kim W,et al.Non-alcoholic fatty liver disease across the spectrum of hypothyroidism[J].J Hepatol,2012,57(1):150-156.
• [24]Musso G,Cassader M,Rosina F,et al.Impact of current treatments on liver disease,glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease(NAFLD):a systematic review and meta-analysis of randomised trials[J].Diabetologia,2012,55(4):885-904.
• [25]Sullivan S,Kirk EP,Mittendorfer B,et al.Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease[J].Hepatology,2012,55(6):1738-1745.
• [26]Keating SE,Hackett DA,George J,et al.Exercise and non-alcoholic fatty liver disease:a systematic review and meta-analysis[J].J Hepatol,2012,57(1):157-166.
• [27]Le TA,Chen J,Changchien C,et al.Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis:a randomized controlled trial[J].Hepatology,2012,56(3):922-932.
• [28]Parker HM,Johnson NA,Burdon CA,et al.Omega-3supplementation and non-alcoholic fatty liver disease:a systematic review and meta-analysis[J].J Hepatol,2012,56(4):944-951.
• [29]Newsome PN,Allison ME,Andrews PA,et al.Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis[J].Gut,2012,61(4):484-500.
• [30]Chalasani N,Younossi Z,Lavine JE,et al.The diagnosis and management of non-alcoholic fatty liver disease:practice Guideline by the American Association for the Study of Liver Diseases,American College of Gastroenterology,and the American Gastroenterological Association[J].Hepatology,2012,55(6):2005-2023.